Shen Jing, Wang Run-Tian, Xu Yao-Chu, Wang Li-Wei, Wang Xin-Ru
Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, 701 West 168th Street (Room 505), New York, NY 10032, USA.
World J Gastroenterol. 2005 Oct 14;11(38):6056-60. doi: 10.3748/wjg.v11.i38.6056.
To explore the interaction models of the cytochrome P-450 (CYP) 1A1 Val variant and glutathione S-transferase (GST) M1 null polymorphisms with tobacco smoking in the occurrence of intestinal gastric cancer.
A community-based case-control study was conducted in Yangzhong. Subjects included 114 intestinal types of gastric cancer with endoscopic and pathological diagnosis during January 1997 and December 1998, and 693 controls selected from their spouse, siblings or siblings-in-law who had no history of digestive system cancer. Logistic regression was used to estimate the interaction models.
The frequency of the CYP1A1 Val variant allele in cases did not differ from that in controls. The OR of GSTM1 null genotype was 2.0 (95% confidence interval (95%CI): 1.2-3.1, P<0.01). It showed a significant type 2 form of interaction model when both CYP1A1 Val variant allele and former tobacco smoking existed (i.e., among the multiplicative effects, the disease risk is increased by the tobacco exposure alone but not by the CYP1A1 variant alone). The interaction index gamma was 2.8, and OR(eg) (95%CI) was 5.0 (1.9-13.4). GSTM1 null genotype and former tobacco smoking were significant in a type 4 interaction model (i.e., the disease risk is increased by GSTM1 null genotype or tobacco exposure alone among the multiplicative effects). The interaction index gamma and OR(eg) (95%CI) were 3.4 and 8.4 (3.4-20.9), respectively.
Different interaction models of CYP1A1 Val variant allele and GSTM1 null genotype with tobacco smoking will contribute to understanding carcinogenic mechanism, but there is a need to further investigate in larger scale studies.
探讨细胞色素P-450(CYP)1A1 Val变异体和谷胱甘肽S-转移酶(GST)M1无效多态性与吸烟在胃肠癌发生中的相互作用模式。
在扬中进行了一项基于社区的病例对照研究。研究对象包括1997年1月至1998年12月期间经内镜和病理诊断的114例肠型胃癌患者,以及从其配偶、兄弟姐妹或姻亲中选取的693名无消化系统癌症病史的对照。采用逻辑回归估计相互作用模式。
病例组中CYP1A1 Val变异等位基因的频率与对照组无差异。GSTM1无效基因型的比值比(OR)为2.0(95%置信区间(95%CI):1.2 - 3.1,P<0.01)。当CYP1A1 Val变异等位基因和既往吸烟同时存在时,显示出显著的2型相互作用模式(即,在相乘效应中,疾病风险仅由烟草暴露增加,而不由CYP1A1变异单独增加)。相互作用指数γ为2.8,OR(eg)(95%CI)为5.0(1.9 - 13.4)。GSTM1无效基因型和既往吸烟在4型相互作用模式中具有显著性(即,在相乘效应中,疾病风险仅由GSTM1无效基因型或烟草暴露增加)。相互作用指数γ和OR(eg)(95%CI)分别为3.4和8.4(3.4 - 20.9)。
CYP1A1 Val变异等位基因和GSTM1无效基因型与吸烟的不同相互作用模式将有助于理解致癌机制,但需要在更大规模的研究中进一步调查。